Next Article in Journal
FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review
Next Article in Special Issue
Additive Intralesional Interleukin-2 Improves Progression-Free Survival in a Distinct Subgroup of Melanoma Patients with Prior Progression under Immunotherapy
Previous Article in Journal
CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
Previous Article in Special Issue
Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity
 
 
Review

Article Versions Notes

Action Date Notes Link
article xml file uploaded 24 December 2021 12:13 CET Original file -
article xml uploaded. 24 December 2021 12:14 CET Update https://www.mdpi.com/2072-6694/14/1/85/xml
article pdf uploaded. 24 December 2021 12:14 CET Version of Record https://www.mdpi.com/2072-6694/14/1/85/pdf
article html file updated 24 December 2021 12:15 CET Original file -
article html file updated 31 July 2022 00:19 CEST Update https://www.mdpi.com/2072-6694/14/1/85/html
Back to TopTop